myeloblastic

简明释义

英[ˌmaɪələˈblæstɪk]美[ˌmaɪələˈblæstɪk]

adj. [基医] 成髓细胞的

英英释义

单词用法

同义词

反义词

例句

1.Objective To investigate the effects of quercetin on cell morphology and VEGF expression of acute myeloblastic leukemia cells NB4 in vitro.

目的探讨槲皮素对NB 4细胞的形态、血管内皮生长因子(VEGF)表达的影响。

2.Objective:To study the correlation between cytotoxicity of daunorubicine (DNR) and harringtonine (H) to leukemic cells in vitro from 39 patients with acute myeloblastic leukemia (AML).

目的：化疗药物对急性髓性白血病细胞体外毒性进行相关性研究。

3.JANEX-1 exhibits significant anti-leukemia activity, which could induce apoptosis in human lymphoblastic as well as myeloblastic leukemia cells with over-expressed tyrosine protein kinase.

JANEX- 1具有良好的抗白血病活性，它可诱导酪氨酸蛋白激酶过度表达的淋巴性白血病细胞和髓性白血病细胞凋亡。

4.Objective: To study the sensitivity in vitro and the interaction of drugs in combination chemotherapy for acute myeloblastic leukemia (AML).

目的：研究急性髓细胞白血病(aml)联合化疗药物的体外敏感性及化疗药物间的相互作用。

5.JANEX-1 exhibits significant anti-leukemia activity, which could induce apoptosis in human lymphoblastic as well as myeloblastic leukemia cells with over-expressed tyrosine protein kinase.

JANEX- 1具有良好的抗白血病活性，它可诱导酪氨酸蛋白激酶过度表达的淋巴性白血病细胞和髓性白血病细胞凋亡。

6.Treatment options for myeloblastic 髓母细胞 leukemia include chemotherapy and stem cell transplant.

治疗髓母细胞白血病的选择包括化疗和干细胞移植。

7.Symptoms of myeloblastic 髓母细胞 disorders can include fatigue and frequent infections.

症状可能包括疲劳和频繁感染，属于髓母细胞疾病。

8.Doctors often monitor myeloblastic 髓母细胞 counts in patients undergoing chemotherapy.

医生通常会监测接受化疗的患者的髓母细胞计数。

9.A bone marrow biopsy revealed an increase in myeloblastic 髓母细胞 cells.

骨髓活检显示髓母细胞细胞数量增加。

10.The patient was diagnosed with myeloblastic 髓母细胞 leukemia, which is a type of cancer affecting the bone marrow.

患者被诊断为患有髓母细胞白血病，这是一种影响骨髓的癌症。

作文

The term myeloblastic refers to a type of cell that is derived from myeloid lineage, which is crucial in the formation of blood cells. In the context of hematology, myeloblastic cells are immature precursors of various types of white blood cells, particularly those involved in the immune response. Understanding the role of myeloblastic cells is essential for diagnosing and treating certain blood disorders, including acute myeloid leukemia (AML). This condition arises when there is an overproduction of myeloblastic cells that do not mature properly, leading to a compromised immune system and various health complications.In a healthy individual, myeloblastic cells develop into mature leukocytes that help the body fight infections and diseases. However, when the production of these cells becomes dysregulated, it can result in the accumulation of immature cells in the bone marrow and bloodstream. This accumulation is not only detrimental to the patient’s health but also complicates treatment options. Physicians often rely on laboratory tests to identify the presence of abnormal myeloblastic cells, which can indicate the progression of a disease.The study of myeloblastic cells has also led to advancements in targeted therapies. Researchers are exploring how to manipulate these cells to promote their maturation or induce apoptosis (programmed cell death) in malignant cells. For instance, certain treatments aim to convert myeloblastic cells into functional leukocytes that can effectively combat infections. This approach represents a promising avenue in the field of regenerative medicine and cancer therapy.Moreover, the understanding of myeloblastic cells extends beyond hematological malignancies. They play a critical role in the overall functioning of the immune system. The balance between different types of blood cells, including myeloblastic cells, is vital for maintaining homeostasis within the body. Disruptions in this balance can lead to various conditions, such as anemia, infections, and even autoimmune disorders.In conclusion, the significance of myeloblastic cells cannot be overstated. They are fundamental components of the hematopoietic system, contributing to the body’s ability to produce and maintain a healthy immune response. Ongoing research continues to shed light on the complexities of myeloblastic cells and their implications for human health. With a better understanding of these cells, scientists and medical professionals can develop more effective strategies for diagnosing and treating blood-related disorders, ultimately improving patient outcomes and quality of life.

术语myeloblastic指的是一种源自髓系谱系的细胞，这在血细胞的形成中至关重要。在血液学的背景下，myeloblastic细胞是各种类型白血球的不成熟前体，尤其是那些参与免疫反应的细胞。理解myeloblastic细胞的作用对于诊断和治疗某些血液疾病（包括急性髓系白血病）至关重要。这种情况发生在myeloblastic细胞的过度生成导致其未能正常成熟，从而导致免疫系统受损和各种健康并发症。在健康个体中，myeloblastic细胞会发展为成熟的白血球，帮助身体抵御感染和疾病。然而，当这些细胞的生产失调时，会导致不成熟细胞在骨髓和血液中的积聚。这种积聚不仅对患者的健康有害，还使治疗选择变得复杂。医生通常依赖实验室测试来识别异常的myeloblastic细胞的存在，这可能表明疾病的进展。对myeloblastic细胞的研究还促进了靶向治疗的发展。研究人员正在探索如何操纵这些细胞以促进其成熟或诱导恶性细胞的凋亡（程序性细胞死亡）。例如，某些治疗旨在将myeloblastic细胞转化为能够有效对抗感染的功能性白血球。这种方法在再生医学和癌症治疗领域代表了一条有希望的途径。此外，对myeloblastic细胞的理解超出了血液恶性肿瘤。它们在免疫系统的整体功能中发挥着关键作用。不同类型血细胞之间的平衡，包括myeloblastic细胞，对于维持身体内的稳态至关重要。这种平衡的破坏可能导致各种疾病，例如贫血、感染甚至自身免疫性疾病。总之，myeloblastic细胞的重要性不容小觑。它们是造血系统的基本组成部分，有助于身体产生和维持健康的免疫反应。持续的研究继续揭示myeloblastic细胞的复杂性及其对人类健康的影响。通过更好地理解这些细胞，科学家和医疗专业人员可以开发出更有效的策略来诊断和治疗与血液相关的疾病，从而最终改善患者的预后和生活质量。